Prelude Therapeutics Incorporated

PRLD39

Penny Stock

$4.85arrow_drop_up0.83%$0.04

Penny Stock

PRLD39

$4.85

arrow_drop_up0.83%$0.04

Penny Stock

Performance History

Key Stats
Open	$4.80
Prev. Close	$4.81
EPS	-1.63
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$261.92M
PE Ratio	-

	LOW	HIGH
Day Range	4.65	4.91
52 Week Range	1.66	6.80

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-1.63

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Prelude Therapeutics Incorporated (PRLD)

Prelude Therapeutics Incorporated (PRLD) is a pharmaceutical company that focuses on the discovery and development of small molecule therapies for cancer and rare diseases. The company is dedicated to transforming the lives of patients through the advancement of precision medicine. With a strong pipeline and innovative approach, Prelude Therapeutics is poised to make a significant impact in the field of oncology.

PRLD's stock price history reflects the growing interest and confidence in the company's potential. Over the years, the stock has shown consistent growth, with periodic fluctuations influenced by market conditions and industry trends. Investors have recognized the value and potential of Prelude Therapeutics, leading to a steady increase in the stock's price over time.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Krishna Vaddi D.V.M., Ph.D.
Headquarters: Wilmington
Employees: 122
Exchange: NASDAQ

add Prelude Therapeutics Incorporated to watchlist

Keep an eye on Prelude Therapeutics Incorporated

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Prelude Therapeutics Incorporated's (PRLD) price per share?

The current price per share for Prelude Therapeutics Incorporated (PRLD) is $4.85. The stock has seen a price change of $0.04 recently, indicating a 0.83% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Prelude Therapeutics Incorporated (PRLD)?

For Prelude Therapeutics Incorporated (PRLD), the 52-week high is $6.8, which is 40.21% from the current price. The 52-week low is $1.66, the current price is 192.17% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Prelude Therapeutics Incorporated (PRLD) a growth stock?

Prelude Therapeutics Incorporated (PRLD) has shown an average price growth of 0.41% over the past three years. It has received a score of 15 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Prelude Therapeutics Incorporated as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Prelude Therapeutics Incorporated (PRLD) stock price performance year to date (YTD)?

As of the latest data, Prelude Therapeutics Incorporated (PRLD) has a year-to-date price change of 19.16%. Over the past month, the stock has experienced a price change of -13.24%. Over the last three months, the change has been 28.31%. Over the past six months, the figure is 16.31%.

help

Is Prelude Therapeutics Incorporated (PRLD) a profitable company?

Prelude Therapeutics Incorporated (PRLD) has a net income of -$121.83M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$132.28M. Furthermore, the EBITDA is -$140.78M.

help

What is the market capitalization of Prelude Therapeutics Incorporated (PRLD)?

Prelude Therapeutics Incorporated (PRLD) has a market capitalization of $261.93M. The average daily trading volume is 308.09K, indicating the stock's liquidity and investor engagement.